ConductScience.org, home

Library / Trials

Effects of Caffeine on EEG Theta/Beta Ratio and Cognitive Control

NCT02940808, Not applicable, Completed, Leiden University Medical Center

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleEffects of Caffeine on EEG Theta/Beta Ratio and Cognitive ControlClinicalTrials.gov
NCT numberNCT02940808ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment41 participants, actualClinicalTrials.gov
Lead sponsorLeiden University Medical CenterClinicalTrials.gov
ConditionsCaffeineClinicalTrials.gov
InterventionsCaffeine (200mg), PlaceboClinicalTrials.gov
First posted2016-10-21ClinicalTrials.gov
Last updated2017-03-08ClinicalTrials.gov

Registered outcomes 13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryAttentional focus (RT)Approx. 45 min after capsule consumptionTACT focus RTs on incongruent v congruent (correct) trials.ClinicalTrials.gov
PrimaryAttentional shift (RT)Approx. 45 min after capsule consumptionTACT shift RTs on post-shift trials compared to pre-shift (correct) trials.ClinicalTrials.gov
PrimaryEmotional interference (RT)Approx. 70 min after capsule consumptionEmotional Stroop Task RTs for neutral, positive, and negative (correct) trials.ClinicalTrials.gov
PrimaryEEG theta/beta ratioApprox. 30 min after capsule consumptionFor mediation analyses, change in EEG theta/beta ratio after caffeine consumption relative to placebo consumption.ClinicalTrials.gov
PrimaryEEG theta/beta ratioBaselineFor moderation analyses, baseline-measured spontaneous EEG theta/beta ratio.ClinicalTrials.gov
PrimarySpontaneous eye-blink ratesBaselineFor moderation analyses, baseline-measured spontaneous eye-blink rates.ClinicalTrials.gov
PrimaryTrait anxietyBaselineSelf-reported trait anxiety (STAI-t)ClinicalTrials.gov
PrimaryWorking memory (ACC)Approx. 60 min after capsule consumptionN-Back accuracy (% correct) in the 1-back and 3-back conditions.ClinicalTrials.gov
PrimaryWorking memory (RT)Approx. 60 min after capsule consumptionN-Back RTs on correct trials in the 1-back and 3-back conditions.ClinicalTrials.gov
SecondaryAttentional focus (ACC)Approx. 45 min after capsule consumptionTACT focus accuracy on incongruent v congruent trials.ClinicalTrials.gov
SecondaryAttentional shift (ACC)Approx. 45 min after capsule consumptionTACT shift accuracy on post-shift trials compared to pre-shift trials.ClinicalTrials.gov
OtherTBR and ACSBaselineRelation between TBR and ACS.ClinicalTrials.gov
OtherTBR and STAI-tBaselineRelation between TBR and STAI-t.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 14

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
6187540BACKGROUNDPubMed
6640274BACKGROUNDPubMed
10945922BACKGROUNDPubMed
12003445BACKGROUNDPubMed
12559224BACKGROUNDPubMed
15997602BACKGROUNDPubMed
17516812BACKGROUNDPubMed
19455173BACKGROUNDPubMed
19897008BACKGROUNDPubMed
20816912BACKGROUNDPubMed
21531388BACKGROUNDPubMed
23241646BACKGROUNDPubMed
24379166BACKGROUNDPubMed
27555290BACKGROUNDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 3

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
1-Back TaskPrimary outcomeConductCognition
Emotional Stroop TaskPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)